In a recent phase 2 clinical trial, the cancer drug bexarotene was found to regenerate the myelin sheath—the target of the autoimmune disorder multiple sclerosis, or MS. A protective lipid layer around nerves in the brain and spinal cord, the myelin sheath is targeted by immune cells incorrectly in patients with MS, resulting in the […]
The post Drug Actually Repairs Nerve Damage, Giving Scientists Hope For Future MS Treatment appeared first on Good News Network.
In a recent phase 2 clinical trial, the cancer drug bexarotene was found to regenerate the myelin sheath—the target of the autoimmune disorder multiple sclerosis, or MS. A protective lipid layer around nerves in the brain and spinal cord, the myelin sheath is targeted by immune cells incorrectly in patients with MS, resulting in the
The post Drug Actually Repairs Nerve Damage, Giving Scientists Hope For Future MS Treatment appeared first on Good News Network.